Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, September 16, 2016
United Airlines (UAL) and DHL Global Forwarding, the air and ocean freight specialist within Deutsche Post DHL Group, have announced several significant growth and expansion initiatives in Puerto Rico. The two companies are working together to ...
read more
Sunday, September 18, 2016
The Cystic Fibrosis Foundation has announced the official opening of a new, one-of-a kind research facility in Lexington, Mass. Operated by Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), an affiliate of the CF Foundation, the lab is designed to...
read more
Sunday, September 18, 2016
Navidea Biopharmaceuticals has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion for a new Lymphoseek® 50 microgram kit for radiopharmaceutical preparation.
read more
Sunday, September 18, 2016
Pharmaceutical Research and Manufacturers of America (PhRMA) president and CEO Stephen J. Ubl issued the following statement on the release of the Biosimilar User Fee Act (II) performance goals letter.
read more
Sunday, September 18, 2016
EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt,Germany in the US and Canada, has announced the appointment of Craig Millian as Senior Vice President, Neurology and Immunology.
read more
Monday, September 19, 2016
DiscoverX Corporation, a supplier of innovative cell-based assays and services for drug discovery and development, today has announced the launch of the SAFETYscan™ in vitro pharmacological profiling services, providing scientists an advanced ...
read more
Monday, September 19, 2016
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has completed the previously announced acquisition of Clinical Research Management, Inc. (ClinicalRM).
read more
Monday, September 19, 2016
Jubilant Biosys Ltd has announced two new leadership appointments. Mr. Steven Hutchins has been appointed as President and Dr. Takeshi Yura has been appointed as Vice President of Medicinal Chemistry.
read more
Monday, September 19, 2016
PAREXEL International Corporation a global biopharmaceutical services organization, has announced the appointment of Christian Dreger, Ph.D., as Senior Vice President, PAREXEL Access and PAREXEL Consulting.
read more
Monday, September 19, 2016
Avara Pharmaceutical Services, Inc. recently celebrated their first year since the acquisition of their Arecibo, Puerto Rico, site from Merck. Since that time, Avara, headquartered in Norwalk, CT, (USA), now has four manufacturing facilities with ...
read more
Tuesday, September 20, 2016
Custom Pharma Services, a full-service contract development and manufacturing organization (CDMO), has acquired a new building to expand its high containment manufacturing and development operations.
read more
Thursday, September 22, 2016
Slovakia-based contract development and manufacturing organization (CDMO) Saneca Pharma has added senior talent to its team to position the company for its next phase of growth.
read more
Thursday, September 22, 2016
Chesapeake IRB, a provider of independent institutional review board services for the life science industry, has hired Randall Hein, an executive with more than 20 years of experience in operations, sales and consulting for life science organizations...
read more
Thursday, September 22, 2016
Johnson Matthey, a provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, announced that its facilities in Annan, UK, have been approved for GMP manufacturing following an extensive program of ...
read more
Thursday, September 22, 2016
Crown Bioscience, a wholly owned subsidiary of Crown Bioscience International and a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has published a further ...
read more